Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02704039 · ClinicalTrials.gov registry record

Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin

A clinical trial, sponsored by University of Texas at Austin.

Completed
Registry status
239
Enrollment target

NCT02704039: Completed study, sponsored by University of Texas at Austin.

NCT02704039 is a clinical trial that has completed, run by University of Texas at Austin. The registered enrollment target is 239 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02704039 has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
239 participants
Enrollment target

Study Summary

The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluorescence spectroscopy) from skin lesion sites. In order to accomplish this objective, the investigators propose to: 1) develop biophysical model for Raman spectroscopy of skin cancers, 2) conduct a clinical pilot study to collect MMS data from a minimum of 250 patients to determine the diagnostic accuracy (sensitivity and specificity) of MMS for diagnosing skin malignancy.

Primary Outcome

use of a new technique of biophysical modeling to analyze the Raman spectra. At the core of the technique is the measurement of a set of "basis spectra" which are fit to the data using ordinary least-squares.

Trial Details

FieldValue
Enrollment Target 239 participants
Start Date 2016-01
Est. Completion 2018-12
University of Texas at Austin

257 total trials

What the finished NCT02704039 record still lists

NCT02704039 is an observational study that tracks outcomes without assigning an intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02704039 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02704039 about?

NCT02704039 is a clinical study titled "Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin". The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluoresc...

What is the current status of trial NCT02704039?

This trial is currently completed. The enrollment target is 239 participants. The study started on 2016-01. Estimated completion is 2018-12.

Who is sponsoring clinical trial NCT02704039?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02704039, the US trial registry maintained by the National Library of Medicine. NCT02704039 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.